Recent Headlines
knowRX Strengthens Platform to Support Physician Engagement in Clinical Trial Diversity
knowRX, a clinical trial solutions provider, has launched an Investigator/Provider Learning Center on its PIXS™ platform, focusing on "Cultural Considerations in the Conduct of Clinical Trials." This initiative aims to educate physicians, increasing their awareness and understanding of clinical trials. The goal is to bridge gaps in patient access and awareness, particularly among underrepresented populations, aligning with recent FDA guidelines emphasizing diversity in clinical trials. - October 07, 2023 - knowRX, Inc.
Cayman Chemical Introduces a New Tool to Study Protein-Lipid Interactions
Cayman LipiDOT Strips™ are a simple tool for the rapid identification of protein-lipid interactions. Researchers can screen a protein of interest against 22 biologically relevant lipids in one assay in a single day at a lower price compared with existing commercial options. - October 04, 2023 - Cayman Chemical Company
GeneProof Announces Expansion of Its IVDR-Certified PCR Portfolio
GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027. Currently,... - October 03, 2023 - ALPCO
Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase
The Gotham Biotech Histoplasma Urinary Antigen EIA is an enzyme immunoassay (EIA) intended to qualitatively detect the presence of Histoplasma capsulatum galactomannan antigen in human urine specimens. This kit, when used in conjunction with other diagnostic measures, can be used as an aid in the diagnosis of histoplasmosis. - September 08, 2023 - Gotham Biotech
Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington’s Disease
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease (HD), today shares that the Phase 3 pivotal KINECT®-HD study conducted by HSG in collaboration with Neurocrine Biosciences,... - August 18, 2023 - Huntington Study Group
Huntington Study Group Announces Positive Topline Results for Virtual Unified Huntington’s Disease Rating Scale® (vUHDRS®) Study
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces positive topline results from its Virtual Unified Huntington’s Disease Rating Scale®... - August 14, 2023 - Huntington Study Group
Minus K Technology Announces Announces Its Eighth U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
Minus K Technology, over the past 30 years has worked with businesses, universities and laboratories all over the world, supplying negative-stiffness vibration isolation products for research within universities, aerospace, audio reproduction, crystal growth, neuroscience, biology, chemistry,... - August 09, 2023 - Minus K Technology Inc.
VitaliNatura Essentials™ Launches Exclusive Product Line for Women in Mid-Life and Beyond
VitaliNatura Essentials™, a 100% women-owned company, proudly launches an exclusive product line for women in mid-life and beyond. The collection includes premium vitamins and supplements tailored to cater to the unique needs of women in their mid-40s and after. The company's commitment to quality and empowerment shines through as they offer Adrenal Support Supplements, Magnesium Gummies, Sea Moss Gummies, Liver Support Capsules, Berberine Complex, Joint Health Capsules, and more. - August 01, 2023 - VitaliNatura Essentials DBA EngagePro Digital, LLC
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD
HSG Clinical Research, Inc. - the Huntington Study Group’s clinical research organization (CRO) and wholly owned subsidiary (collectively referred to here as HSG) - has begun providing CRO services for CHDI Foundation’s Enroll-HD observational study and clinical research platform in the... - July 25, 2023 - Huntington Study Group
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US and Canada-based researchers. - July 13, 2023 - Cayman Chemical Company
Paras Biopharma (Biologics CDMO) Announces Industry Leading Scale-up Development & Production Process of an “Onco-Immunology Fc-fusion Biologic”
Paras Biopharma (Biologics CDMO) Finland team is pleased to announce that its extensive efforts have resulted in the successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” biologic. - July 12, 2023 - Paras Biopharmaceuticals Finland Oy
Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression in Microbial Systems – To Facilitate Economical Scale-Up in Production of Biologics
Paras Biopharma (Biologics CDMO) Finland, a leading biopharmaceutical technology development company in the Nordic region, maximises recombinant protein expression in Microbial Systems in its fully-equipped biologics production facility in Finland. - July 04, 2023 - Paras Biopharmaceuticals Finland Oy
Tialma's Aleksey Krylov Attending NewYorkBIO Life Science Company Showcase
Tialma, a CFO consultancy to the life science companies, is sharing that its lead consultant Aleksey Krylov will attend the highly anticipated NewYorkBIO Life Science Company Showcase, scheduled to take place on June 27, 2023. The NewYorkBIO Life Science Company Showcase is an esteemed event that... - June 27, 2023 - Tialma
Aleksey Krylov Joining Oncology Advanced Practice Forum Online Conference
Tialma, a CFO consultancy to the life science companies, is sharing that its lead consultant Aleksey Krylov will join Oncology Advanced Practice Forum Online Conference, scheduled to take place on June 26, 2023. Tialma chose this event because of its versatility, which enables networking... - June 26, 2023 - Tialma
Alventa Pharma Pvt. Ltd. Introduces Affordable Generic Pharmaceutical Drugs and Extends Contract Manufacturing Services
India-based Alventa Pharma, a leading third party manufacturing pharma, is excited to announce the launch of their cost-effective generic drugs in both domestic and international markets. Alongside being Third party manufacturing pharma, Alventa Pharma now expands its services as a contract... - June 21, 2023 - Alventa Pharma Limited
PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars
ALPCO Receives FDA 510(k) Clearance for the Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay. The Calprotectin Immunoturbidimetric (IT) Assay is now IVDD and 510(k)-cleared for in... - June 15, 2023 - ALPCO
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
GenInvo Part of PHUSE US Connect & Informa Connect Clinical Data Disclosure, Transparency & Plain Language Summaries Event - 2023
GENINVO was a part of 2 recent global events for the life science industry. The first was "PHUSE US Connect 2023" which was held in Renaissance Orlando at SeaWorld Florida on 5th – 8th March 2023 and the second event, Informa Connect Clinical Data Disclosure, Transparency &... - June 05, 2023 - GenInvo, Inc.
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
OPTI•MIST® Introduces Innovative Organic Personal Care Products
OPTI•MIST® Organic Introduces Innovative Organic Personal Care Products Infused with a Powerful Mineral-Based Antiseptic for Enhanced Hygiene. OPTI•MIST, a pioneering brand in the personal care industry, is pleased to announce the launch of its revolutionary line of organic personal... - May 26, 2023 - OPTI-LAB INC.
The Inc. Magazine, USA Includes Paras Biopharma (Biologics CDMO) as One of the Top 10 Most Innovative Biotech Companies to Follow in 2023
Paras Biopharma (Biologics CDMO), a biopharmaceutical technology development company is pleased to be included by The Inc. Magazine, USA as “One of the Top 10 Most Innovative Biotech Companies to Follow in 2023.” The Inc. Magazine serves as an online "go-to" informative tool for business leaders and entrepreneurs, including CEOs and owners of small-to-midsize companies to success, providing news, advice, and inspirational articles. - May 19, 2023 - Paras Biopharmaceuticals Finland Oy
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company
Liberum Independent Medical Education Announces Management Buyout
Liberum Independent Medical Education, provider of independent medical education (IME) to healthcare professionals worldwide, has announced a management buyout (MBO) from its original owner, OHC London Holdings Ltd. The MBO was led by the company's Managing Director, Celeste Kolanko who has taken ownership of the company which now operates as Liberum IME BV, and Liberum Independent Medical Education Ltd. - April 29, 2023 - Liberum Independent Medical Education Ltd
How to Select the Right Load Movement System - Podcast Now Available
AeroGo, manufacturer of innovative load moving equipment, launched a new seven-episode podcast, called, "Select the Right Load Movement System." Each episode covers a specific question used to narrow down the choices available to the listener’s situation. - April 26, 2023 - AeroGo, Inc.
Johari Digital Makes a Significant Contribution from Their CSR Fund to Support Innovation, Research & Incubation at IIT, Jodhpur
As a part of the Industry and Academia collaboration, Johari Digital Healthcare Ltd. donated a significant funding amount to IIT, Jodhpur Incubation & Innovation center from their CSR Fund to boost & strengthen Med-Tech Startup Ecosystem. Mr. Satyendra Johari, Executive Chairman &... - April 24, 2023 - Johari Digital Healthcare Ltd.
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
DistillerSR Appoints New Board Members to Accelerate Scaleup and Healthcare Analytics Domain Expertise
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today welcomed Dr. Khaled El Emam and Jason Flick as new board members. The two serial entrepreneurs join Andrew Pinkerton, Partner at Thomvest Ventures, Maria Pacella,... - April 11, 2023 - DistillerSR
New Collagen for Skin and Beauty | Fitness Researchers May Shift Beauty Care Towards Advanced Sports Methods
Newly formulated collagen for fitness lifts the anti-aging and natural-beauty effects simultaneously. Vigor™, a health and fitness nutrition company specializing in bodybuilding proteins, has led the development. Sports proteins have always been at the forefront of nutritional innovation, yet, collagen is a protein type that only recently entered gym routines. Researchers have unveiled its benefit to the full extent for the first time. - April 11, 2023 - Vigor LLC
Distinguished RN Joins the 910AM Superstation Radio Host Lineup as the First Registered Nurse Through Her New Talk Radio Show "Nurse Charms LIVE"
Charmaine Bond AKA “Nurse Charms” is launching her new, trending, radio talk show in celebration of her brand “Nurse Charms”®️ becoming a Registered Trademark. Nurse Charms has spent over 20 years in her nursing career with a passion and dedication for helping... - April 10, 2023 - Nurse Charms
Dr. V. Kim Kutsch Releases New Podcast, "Contrary to Ordinary"
On March 21, 2023 Dr. V. Kim Kutsch, CEO of Oral BioTech and founder of CariFree, released a podcast titled “Contrary to Ordinary.” Dr. Kutsch aims to uncover the common threads that make people extraordinary. Each bi-weekly episode will showcase a thought leader in the dental industry... - March 30, 2023 - Oral BioTech
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
A New Philosophy for Jamaican Pot
Massive Therapeutics, a medical cannabis company, has released its list of the most important reasons organic farming techniques should be implemented over non-organic. Cannabis has a long history, from its use in traditional medicine to its current status as a lucrative crop. In Jamaica, the... - March 27, 2023 - Massive Therapeutics
HSG Announces 30th Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group
Gallant Deepens Its Bench by Adding Dr. Valentine Williams as Senior Vice President of Clinical Development and Regulatory
Furthering its mission to bring regenerative medicine to all pets, animal biotech company Gallant Therapeutics welcomes an industry leader, Dr. Val Williams, to its pioneering team. - March 17, 2023 - Gallant
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
Dr. Ainhoa de Federico to Receive Honorary Doctorate; International Award Recognizes Achievements in Natural Vision and Holistic Health & Healing
Creator of the ClearSight Method of natural vision improvement, Dr. Ainhoa de Federico is one of the world’s leading holistic natural vision educators. Her dedication to research, education, teaching and social impact has had a profound impact on the lives of countless individuals in more than 200 countries, and her work has inspired many in the health and wellness community. - March 14, 2023 - Dr. Ainhoa de Federico
GENINVO Launches Its Latest Offering – Datalution
GenInvo, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Datalution. GenInvo has recognized various challenges the pharmaceutical industry faces, especially in generating data for clinical trials. The need of clinical data to... - March 11, 2023 - GenInvo, Inc.
Nuvi Global Congratulates Julio Chavez's Promotion
Julio’s Promotion is a sure sign of a successful win within Nuvi Global for now and for the future. - February 23, 2023 - Nuvi Global
Nuvi Global Reveals Weight Management Line
Ontario, California-based wellness unveils a new and effective weight management line to see everyone be their best possible self. - February 23, 2023 - Nuvi Global
North Texas Plastic Surgery to Offer Semaglutide Weight Loss Treatment
The biggest advancement in weight loss treatment is now being offered at North Texas Plastic Surgery in Dallas. - February 17, 2023 - North Texas Plastic Surgery
DistillerSR Launches Industry's Most Comprehensive and Configurable PRISMA 2020 Flow Diagram Reporting Module
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today announced the launch of full support for the PRISMA 2020 report guidelines. DistillerSR’s PRISMA 2020 flow diagram reporting module enables research... - January 31, 2023 - DistillerSR
Ascend Imaging Center in Southfield, Michigan is Offering Free Calcium Score in Honor of February's "American Heart Month"
Ascend Imaging is offering a Free Calcium Score in honor of American Heart Month for the Month of February, leveraging the latest Artificial Intelligence and technology for the 21st century for the nation's #1 killer, heart attacks. - January 31, 2023 - Ascend Imaging Center